Literature DB >> 20227423

A functional polymorphism in the disrupted-in schizophrenia 1 gene is associated with chronic fatigue syndrome.

Sanae Fukuda1, Ryota Hashimoto, Kazutaka Ohi, Kouzi Yamaguti, Yasuhito Nakatomi, Yuka Yasuda, Kouzin Kamino, Masatoshi Takeda, Seiki Tajima, Hirohiko Kuratsune, Yoshiki Nishizawa, Yasuyoshi Watanabe.   

Abstract

AIMS: Disrupted-in schizophrenia 1 (DISC1), identified in a pedigree with a familial psychosis with the chromosome translocation (1:11), is a putative susceptibility gene for psychoses such as schizophrenia and major depressive disorder (MDD). Patients with chronic fatigue syndrome (CFS) report having continuous severe fatigue and many overlapping symptoms with MDD; however, the mechanism and effective treatment of CFS are still unclear. We focused on the overlapping symptoms between CFS and MDD and performed an association study of the functional single-nucleotide polymorphism (SNP) in the DISC1 gene with CFS. MAIN
METHODS: Venous blood was drawn from CFS patients and controls and genomic DNA was extracted from the whole blood according to standard procedures. Ser704Cys DISC1 SNP was genotyped using the TaqMan 5'-exonuclease allelic discrimination assay. KEY
FINDINGS: We found that the Cys704 allele of Ser704Cys SNP was associated with an increased risk of CFS development compared with the Ser704 allele. SIGNIFICANCE: DISC1 Ser704Cys might be a functional variant that affects one of the mechanisms implicated in the biology of CFS. Some patients with CFS showed a phenotype similar to that of patients with MDD, but further studies are needed to clarify the biological mechanism, because this study is of a rather preliminary nature. Despite the variety of patients with CFS, DISC1 Ser704Cys has an association with CFS, which may also suggest that DISC1 plays a central role in the induction of various psychiatric diseases. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20227423     DOI: 10.1016/j.lfs.2010.03.007

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  4 in total

Review 1.  DISC1 as a therapeutic target for mental illnesses.

Authors:  Takatoshi Hikida; Nao J Gamo; Akira Sawa
Journal:  Expert Opin Ther Targets       Date:  2012-11-06       Impact factor: 6.902

2.  DISC1: Structure, Function, and Therapeutic Potential for Major Mental Illness.

Authors:  Dinesh C Soares; Becky C Carlyle; Nicholas J Bradshaw; David J Porteous
Journal:  ACS Chem Neurosci       Date:  2011-08-05       Impact factor: 4.418

Review 3.  DISC1-binding proteins in neural development, signalling and schizophrenia.

Authors:  Nicholas J Bradshaw; David J Porteous
Journal:  Neuropharmacology       Date:  2010-12-31       Impact factor: 5.250

Review 4.  A narrative review on the similarities and dissimilarities between myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and sickness behavior.

Authors:  Gerwyn Morris; George Anderson; Piotr Galecki; Michael Berk; Michael Maes
Journal:  BMC Med       Date:  2013-03-08       Impact factor: 8.775

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.